Product Background
Abelacimab is under investigation in clinical trial NCT04755283 (Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation).
Product Specification
Alias:NVS250519, F11, anti-F11
Clonity:Monoclonal
Host:CHO Cells
Species:Human
Target:F11
Isotype:IgG1 Lambda
Size:100ug, 1mg, 5mg
Research Area:Cardiovascular
CAS Number:2098724-83-3
Molecular Weight:147.32KDa
Application:ELISA, FACS, Functional Assay, In Vivo
Alternate Names:2098724-83-3, Abelacimab Biosimilar, f11 antibody, biosimilar monoclonal antibodies, Research Grade Biosimilar, biosimilar antibodies, f11 blocking antibody, f11 blocking antibodies, anti-f11 recombinant antibody, f11 recombinant antibody
Purity:>95% as determined by SDS-PAGE
Concentration:batch dependent
Buffer:Supplied in PBS, PH7.5
Storage:Store at -20 °C for 12 months. Store at -80 °C for long term storage.
Note:This product is for research use only.